← Back to all earnings calls

Supernus Pharmaceuticals, Inc. Q1 FY2021 Earnings Call

Supernus Pharmaceuticals, Inc. (SUPN)

Earnings Call FY2021 Q1 Call date: 2021-04-28 Concluded

Share

Quarter scorecard

Revenue

$130.93M

+37.9% YoY

Diluted EPS

$0.11

-72.5% YoY

Net income

$5.69M

-73.5% YoY

Documents & deck